Clinical trials
Observational Arrhythmias, Cardiac trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 15 |
| Recruiting | 13 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital of Ferrara | 7 |
| Medtronic | 5 |
| Abbott Medical Devices | 4 |
| Azienda Ospedaliera Pugliese Ciaccio | 2 |
| Scientific Institute San Raffaele | 2 |
| University of Campania Luigi Vanvitelli | 2 |
| A.O. Ospedale Papa Giovanni XXIII | 1 |
| Abbott | 1 |
| Antonio Rapacciuolo | 1 |
| Azienda Ospedaliera Cardinale G. Panico | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrhythmias, Cardiac | 49 |
| Atrial Fibrillation | 10 |
| Heart Failure | 9 |
| Bradycardia | 7 |
| Death, Sudden, Cardiac | 7 |
| Cardiomyopathies | 3 |
| Heart Diseases | 3 |
| Syncope | 3 |
| Atrioventricular Block | 2 |
| Autoimmune Diseases | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.